Hi Maccaone. The thing to remember is they still only have less than 200 million shares on issue, over 20 million cash in bank. Current market cap $174 m
Downside risk is still not tested in humans and if there are problems with human trials could be worthless.
Upside is if it works in humans and shows no or minimal toxicity then we have the first new antibiotic developed in 30 years that may be effective against multiple bacteria including gram positive, gram negative and the majority of those on WHO most wanted list. All without adding to anti biotic resistance which is a huge issue for most other antibiotics.
because of the low shares on issue then if you regard the upside as being "at least a billion dollars (already 174 mil with no human results) then that would give $5 sp. Of course could go way higher.
RCE Price at posting:
$1.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)